This is a federal contract award made by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, identified as SPE2DE24DA017|SPE2D625F2H18, is for the supply of an "Implant System, Sutureloc" product, with a ceiling value of $2,200.44. The contract is a delivery order, with a fixed price pricing type and an ultimate completion date of March 11, 2025.
Arthrex Inc. is a for-profit Subchapter S Corporation based in Naples, Florida, that specializes in developing, manufacturing, and supplying advanced orthopedic products, surgical implants, instruments, and biologics. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, identified as SPE2DE24D0020, valued at $471,048,172.66 and running from June 11, 2024, to September 1, 2029. This IDC allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders, covering a comprehensive range of orthopedic products.
The contract award does not have a set-aside designation, indicating Arthrex's strong competitive position in the federal marketplace. To date, Arthrex has received over $550,000 in delivery orders under the IDC, demonstrating its capability to support government healthcare systems with advanced medical technologies.
Generated 6/5/25, 9:47 AM